Anti-p53 antibodies in patients with dermatomyositis/polymyositis

Clin Rheumatol. 2007 Aug;26(8):1328-31. doi: 10.1007/s10067-006-0473-1. Epub 2006 Nov 21.

Abstract

Dermatomyositis/polymyositis (DM/PM), which is often accompanied by various immunological abnormalities, was reported to be associated with an increased incidence of malignancies. In this study, we analyzed serum levels of anti-p53 antibody (anti-p53 Ab) in DM/PM patients and in normal controls. Serum levels of anti-p53 Abs were significantly higher in DM/PM patients than those in healthy controls. However, there was no significant difference between serum levels in patients with malignancies and those in patients without malignancies. Anti-p53 Abs were positive in 13% (4 out of 31) of the DM/PM patients. Of these four patients, only one had an internal malignancy. Immunoglobulin G levels were significantly higher in patients positive for anti-p53 Ab than those who were not. These results seemed to suggest that the presence of anti-p53 Abs in DM/PM patients is due to immunological abnormalities in this disease.

MeSH terms

  • Adult
  • Autoantibodies / blood*
  • Case-Control Studies
  • Dermatomyositis / blood*
  • Dermatomyositis / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Male
  • Middle Aged
  • Tumor Suppressor Protein p53 / blood
  • Tumor Suppressor Protein p53 / immunology*

Substances

  • Autoantibodies
  • Tumor Suppressor Protein p53